Next Article in Journal
Construction of a Fluorescent H2O2 Biosensor with Chitosan 6-OH Immobilized β-Cyclodextrin Derivatives
Next Article in Special Issue
Marine Cryptophytes Are Great Sources of EPA and DHA
Previous Article in Journal
Anti-Inflammatory Effects of Curvularin-Type Metabolites from a Marine-Derived Fungal Strain Penicillium sp. SF-5859 in Lipopolysaccharide-Induced RAW264.7 Macrophages
Previous Article in Special Issue
Fatty Acid Profile Is Modulated by Dietary Resveratrol in Rainbow Trout (Oncorhynchus mykiss)
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessArticle
Mar. Drugs 2017, 15(9), 283;

Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer

SCF Pharma, Ste-Luce, QC G0K 1P0, Canada
Department of Biology, Université du Québec à Rimouski, Rimouski, QC G5L 3A1, Canada
Author to whom correspondence should be addressed.
Received: 8 August 2017 / Revised: 23 August 2017 / Accepted: 30 August 2017 / Published: 4 September 2017
(This article belongs to the Special Issue The Sources and Production of Polyunsaturated Fatty Acids)
Full-Text   |   PDF [2050 KB, uploaded 4 September 2017]   |  


Background: There is increasing evidence that marine omega-3 oils are involved in the reduction of cancer risk and progression. However, the anticancer effect of omega-3 monoglyceride on colorectal cancer has yet to be assessed. The goal of this study was to evaluate the anti-cancer effects of eicosapentaenoic acid monoglyceride (MAG-EPA) in HCT116 colorectal carcinoma cells. Methods: The effect of MAG-EPA was evaluated in vitro on HCT116 cells and in vivo on mouse model of HCT116 xenograft. Results: Our data reveal that MAG-EPA decreased cell proliferation and induced apoptosis in HCT116 cells. In a xenograft mouse model, daily per os administration of MAG-EPA reduced tumor growth. Furthermore, MAG-EPA treatments decreased EGFR, VEGFR, and AKT activation pathways and reduced VEGF and HIF1α expression levels in tumors. Conclusion: MAG-EPA may promote apoptosis and inhibit growth of tumors by suppressing EGFR and VEGFR activation pathways. Altogether, these data provide new evidence regarding the mode of action of MAG-EPA in colorectal cancer cells. View Full-Text
Keywords: EPA; colorectal carcinoma; apoptosis; VEGF; EGFR; HIF1α EPA; colorectal carcinoma; apoptosis; VEGF; EGFR; HIF1α

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Morin, C.; Rodríguez, E.; Blier, P.U.; Fortin, S. Potential Application of Eicosapentaenoic Acid Monoacylglyceride in the Management of Colorectal Cancer. Mar. Drugs 2017, 15, 283.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top